
Sign up to save your podcasts
Or


Claim your complimentary gift of my exclusive mini weight care guide today!
Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)
What if Medicare finally made GLP-1 medications for weight management more affordable — could this be the moment that changes access for millions of people?
Today, we're talking about something that's been years in the making in the world of obesity care: the expanded coverage of anti-obesity medications for patients on Medicare. Starting July 1st, eligible Medicare beneficiaries have a real opportunity to access GLP-1 receptor agonist medications at a much more affordable monthly cost through a new federal program — and for many patients, this could mark a major shift in access to treatment that's historically been limited or completely out of reach under Medicare's coverage rules.
This change didn't happen overnight. It comes after years of advocacy, policy discussions, and ongoing efforts to get obesity recognized as a chronic medical condition that deserves treatment just like any other disease. In this episode, we break down where this program came from, how it connects to the bigger picture of obesity care, who it applies to, and everything you need to know about eligibility, covered medications, and how the process actually plays out in real life.
Topics discussed:
Want the full breakdown? This episode covers all the details on eligibility, covered medications, and what this program could mean for you or someone you love navigating Medicare and obesity treatment. Find it wherever you get your podcasts — and if it helps, share it with someone who might need to hear it too.
Resources mentioned in this episode:
Connect with me:
By Dr. Francavilla4.9
6969 ratings
Claim your complimentary gift of my exclusive mini weight care guide today!
Link: Weight Care Guide — Dr. Francavilla Show (thedrfrancavillashow.com)
What if Medicare finally made GLP-1 medications for weight management more affordable — could this be the moment that changes access for millions of people?
Today, we're talking about something that's been years in the making in the world of obesity care: the expanded coverage of anti-obesity medications for patients on Medicare. Starting July 1st, eligible Medicare beneficiaries have a real opportunity to access GLP-1 receptor agonist medications at a much more affordable monthly cost through a new federal program — and for many patients, this could mark a major shift in access to treatment that's historically been limited or completely out of reach under Medicare's coverage rules.
This change didn't happen overnight. It comes after years of advocacy, policy discussions, and ongoing efforts to get obesity recognized as a chronic medical condition that deserves treatment just like any other disease. In this episode, we break down where this program came from, how it connects to the bigger picture of obesity care, who it applies to, and everything you need to know about eligibility, covered medications, and how the process actually plays out in real life.
Topics discussed:
Want the full breakdown? This episode covers all the details on eligibility, covered medications, and what this program could mean for you or someone you love navigating Medicare and obesity treatment. Find it wherever you get your podcasts — and if it helps, share it with someone who might need to hear it too.
Resources mentioned in this episode:
Connect with me:

2,110 Listeners

336 Listeners

67 Listeners

1,680 Listeners

425 Listeners

264 Listeners

230 Listeners

369 Listeners

119 Listeners

162 Listeners

45 Listeners

178 Listeners

42 Listeners

22 Listeners